Combining data-driven design and parallel chemistry for macrocycle development
Founded 2017
Partnered 2019
Cameron Pye
Josh Schwochert
Drugging the 'undruggable' by developing safe and more effective therapeutics that combine the benefits of small and large molecule therapeutics